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Acetylcholinesterase (AChE) is the enzyme that hydrolyzes the neurotransmitter acetylcholine at
cholinergic synapses and neuromuscular junctions. However, results from our laboratory and
others indicate that AChE has an extrasynaptic, noncholinergic role during neural development.
This article is a review of our findings demonstrating the morphogenic role of AChE, using a
neuronal cell culture model. We also discuss how these data suggest that AChE has a cell
adhesive function during neural development. These results could have additional significance as
AChE is the target enzyme of agricultural organophosphate and carbamate pesticides as well as
the commonly used household organophosphate chlorpyrifos (Dursban). Prenatal exposure to
these agents could have adverse effects on neural development by interfering with the
morphogenic function of AChE. - Environ Health Perspect 107(Suppl 1):81-87 (1999).
http.//ehpnetl.niehs.nih.gov/docs/1999/Suppl-1/81-B7bigbee/abstract.html
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Accumulating evidence indicates that
acetylcholinesterase (AChE) has extra-
synaptic functions during neural develop-
ment (1-3). This idea was initially based
on in vivo observations that AChE is tran-
siently expressed by neurons throughout
periods ofaxonal outgrowth prior to synap-
togenesis, a period during which the
classical cholinolytic role for AChE in ter-
minating nervous transmission is unneces-
sary. For example, in the central nervous
system (CNS), Robertson and colleagues
(3,4) have demonstrated transient AChE
activity in thalamic neurons at a time when
their axons are growing into the cerebral
cortex. Similar results have been reported
by Kristt (5) in rat and by Kostovic and
colleagues in developing primates (6). This
expression ofAChE has also been con-
firmed at the messenger RNA level by in
situ hybridization (7). In the chick, tran-
sientAChE expression occurs in developing
spinal cord neurons, which coincides with
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axonal outgrowth from these cells (1,8,9).
In the peripheral nervous system (PNS),
AChE is transiently expressed by develop-
ing dorsal root ganglion (DRG) neurons
(10-14) and later in their axons and
growth cones in the spinal cord (15,16).
Together, these data strongly suggest that
AChE plays a developmental role in the
morphogenesis ofthe nervous system.
Our laboratory has examined this
developmental expression ofAChE in pri-
mary cultures of DRG neurons that are
noncholinergic, yet express high levels of
AChE during neurite outgrowth. This arti-
cle summarizes our results and discusses
possible mechanisms by which AChE may
effect its growth-promoting action.
Materials and Methods
PreparationofDorsal RootGanglion
NeuronalCultures
DRG neuronal cultures were prepared from
E-15 rat embryos as previously described
(17-22). Neurons were plated either onto a
substratum of type I collagen or Matrigel
(Becton Dickinson and Co., Franklin
Lakes, NJ) and maintained in Eagle's mini-
mal essential medium supplemented with
10% NuSerum, 0.3% additional glucose,
and crude nerve growth factor at 37°C with
5% CO2. Matrigel is an artificial basal lam-
ina extract that contains laminin, type IV
collagen, and entactin and forms a highly
permissive substratum for neurite growth.
Cells were plated in the center of 35-mm
culture dishes and extended radially
oriented neuritic processes from this central
plating area. The care and treatment of
experimental animals were conducted in
accordance with guidelines established by
the Institutional Animal Care and Use
Committee, Division ofAnimal Resources,
Virginia Commonwealth University (23).
PharmacologicInhibitorTreatment
After plating, cultures received either 1,5-
bis-(4-allyldimethylammoniumphenyl)-
pentan-3-one dibromide (BW284c51) or
physostigmine at a concentration ranging
from 104 M to 10-7 M or fresh medium
only (18). BW284c51 is a bis-quaternary
nitrogen compound that is a highly specific
inhibitor for AChE. Because of this speci-
ficity, BW284c51 is routinely used to con-
firm AChE activity in both histochemical
and biochemical determinations. Physo-
stigmine is a naturally occurring carbamate
inhibitor ofAChE. These two compounds
were used because they inhibitAChE activ-
ity by different mechanisms. Medium with
or without inhibitors was changed daily.
BW284c51 is used to confirm AChE activ-
ity and as a control for inhibitor treatment,
the butyrylcholinesterase (BChE) inhibitor
tetraisopropyl pyrophosphoramide (iso-
OMPA) substituted for either BW284c51
or physostigmine. BChE was not expressed
in DRG neurons either at the developmen-
tal stage when they were removed from the
embryo (14) or after the cells were placed
in culture (18). Cultures were maintained
for 14 days and then examined by darkfield
microscopy to determine the extent and
pattern ofoutgrowth and by transmission
electron microscopy to reveal ultrastruc-
tural changes. In addition, to assess the dis-
tribution of neurofilaments, the major
cytoskeletal component of neurons, cul-
tures were examined by immunofluores-
cence microscopy as previously described
(19,20), using a monoclonal antibody to
the low molecular weight neurofilament
subunit protein NF68.
MonodonalAntibodyTreatment
Cultures were treated with an AChE
monoclonal antibody, MAB304 (Chemicon
Int'l. Inc., Temecula, CA), using either an
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acute high-dose or a chronic low-dose
exposure protocol as previously described
(22). For the acute treatment, 10-day-old
cultures were exposed to 200 pg/ml of
either MAB304 or normal mouse IgG, or
medium without antibody for 3 hr. For the
chronic studies, 4-day-old cultures received
medium containing 20 pg/ml of either
MAB304 or normal mouse IgG or
medium without antibody for 6 days. The
area of neurite outgrowth was calculated
using a computer-generated perimeter that
extended around the distalmost extent of
the neurites. A representative set ofchron-
ically treated cultures was also examined
by scanning electron microscopy.
AChEAssays
AChE activity was detected histochemi-
cally as previously described (18,19,21),
using acetylthiocholine as the substrate
analog according to the modification of
the method of El Badawi and Schenk
(24). AChE activity was quantified either
by colorimetric analysis based on the
method of Ellman et al. (25), using
acetylthiocholine, or by radiometric assay,
using tritiated acetylcholine, according to
the method of Hall (26) as we have
previously described (18,21).
Results
TheLevel ofAChEExpresion
CorrelateswithNeuriteOutgrowth
Cultured DRG neurons showed a develop-
mental increase in AChE that paralleled the
extent of neurite outgrowth (Figure 1).
AChE expression increased 5-fold between 3
and 7 days in culture (17,18), which is
consistentwith the developmental expression
ofAChE by DRG neurons in vivo(10,14).
ParmacologicInhibitorTreatment
Reduces NeuriteOutgrowth
DRG neurons displayed a dose-dependent
reduction in outgrowth in the presence of
either BW284c5 1 or physostigmine
(Figure 2). No effect on outgrowth was
observed when iso-OMPA was substituted
for either ofthese inhibitors. With increas-
ing doses the outgrowth decreased and
appeared more fasciculated than in control
cultures. For both compounds, at the high-
est doses tested, minimal neurite out-
growth was observed beyond the central
plating area. These results were not due to
differential cell survival as no difference in
cell number was found between control
and treated cultures at the completion of
the experiments. Furthermore, this effect
was reversible as additional outgrowth
occurred and appeared normal after
removal ofeither inhibitor. The inhibitor
concentrations used in these studies were
consistent with values reported in the liter-
ature (27) for inhibition ofAChE in vitro.
The results clearly indicate that the level of
AChE inhibition closely correlated with
the extent ofdecreased outgrowth (Figure
3). Interestingly, co-administration of 1
mM dibutyryl cyclic adenosine monophos-
phate (cAMP) along with BW284c51 sig-
nificantly increased both neurite outgrowth
and AChE expression compared with
inhibitor treatment alone (20).
The esteratic activity ofAChE is used
as a convenient and accurate reporter for
both the cellular localization and level of
AChE expression. However, it is important
to note that the observed effects ofAChE
inhibitors on neurite outgrowth are inde-
pendent ofthe ability ofthese compounds
to inhibit esteratic activity. For example,
we and others (20,28,29) have shown that
irreversible inhibition ofAChE with the
organophosphate diisopropylflurophos-
phate (DFP) has no effect on neurite out-
growth from either CNS or PNS neurons.
These studies indicate that the catalytic
activity ofAChE is not required for its
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Figure 1. AChE activity increases with neurite outgrowth. Darkfield photomicrographs of DRG cultures histochemically stained for AChE activity at day 0, day 2, and day 4
after plating. Small clusters of cells within the plating area express detectable levels ofAChE activity at day 2 (arrows) which becomes prominent byday 4 as a dark reaction
product. This activity increases in both the cell bodies and neurites with time in culture. Quantitation oftheAChE activity is shown in the lowerright panel using a radiometric
assay(21,25). Bar =150 pm for all panels.
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morphogenic function in neurite growth.
Furthermore, not all AChE inhibitors have
the equivalent effect on neurite outgrowth
(Table 1), suggesting that some other
physicochemical property of these mole-
cules accounts for their "neuritostatic" abil-
ity. On the basis of these data, Layer and
colleagues (30) have proposed the sec-
ondary site hypothesis. This premise states
that some, as yet undefined, secondary site
on the AChE molecule is responsible for its
growth-related properties. The ability to
interfere with this site could therefore
depend on the biochemical properties of
the inhibitor molecule, including its shape
and charge.
Pharmacologic InhibitorTreatment
Leads toAlterations in the Neuronal
Cytoskeleton
Along with the retarded neurite out-
growth, 40 to 50% of the neuronal cell
bodies treated with BW284c51 show large
accumulations of neurofilaments (18-20)
(Figure 4A). At the ultrastructural level,
these masses are composed of 10-nm fila-
ments (Figure 4B) and resemble cytoplas-
mic inclusions present in neurons in cases
of cortical atrophy in the CNS and gan-
glioneuroma in the PNS (31). In our
model the accumulation ofneurofilaments
could be due to a direct effect on their pro-
cessing and transport, leading to impaired
outgrowth. Alternatively, AChE inhibitor
treatment could directly perturb neurite
extension and elongation, leading to a sec-
ondary backup ofcytoskeletal elements in
the cell body.
AChEMonodonalAntibodyProduces
NeuriteDetachment andAltered
Neurite Outgrowth
On the basis ofthe results from our studies
using pharmacologic inhibitor treatment,
we examined the effects of a monoclonal
anti-AChE antibody, MAB304, on neurite
outgrowth and attachment (22). Because
this antibody does not inhibit enzyme
activity (22,32), yet causes the morpho-
logic and adhesive changes, its reactive epi-
tope may be related to the secondary,
growth-related site on AChE. We first
determined that the antibody recognized
AChE by immunocytochemical and
enzyme-linked immunosorbent assay
(ELISA) studies (22). We also confirmed
that AChE is on the cell surface and that
antibody binding occurred in unfixed cul-
tures (22). The latter result ensured that
the antibody binds AChE under the exper-
imental conditions used for the perturba-
tion studies. As shown in Figure 5, when
cultures that had been allowed to extend
neurites were exposed to a high concentra-
tion of MAB304 antibody, the distal tips
of the neurites detached within 90 min.
Upon removal of the antibody, new
growth was observed within 8 to 12 hr. In
experiments similar to the pharmacologic
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Figure 2. BW284c51 and physostigmine retard neurite outgrowth. Abbreviation: BW, BW 284c51. Panels Athrough Gare darkfield micrographs of unstained DRG neuron cul-
tures grown for 10 days in medium containing either BW284c51 (A, 104M; B, 10-5M; C, 106 M ) or physostigmine (E, 104M; F, 10-5M) or medium only (Dand G). In each
panel, the central plating area containing the cell bodies is to the left and neurites extend to the right. In both cases, there is a dose-dependent retardation of outgrowth and
an increase in neurite fasciculation, These results are shown graphically in panels Hand L. Results are expressed as means ± SEM. Statistics for differences among the
means were carried out bythe Students t-test. (*p<0.01; **p<0.001). Bar =2 mm for panels A-G.
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inhibitor studies described above, cultures
exposed to low AChE antibody concentra-
tions for 6 days had a 50% reduction in the
area of neurite outgrowth, compared to
treatment with normal mouse IgG and
untreated controls (Figure 6). In addition,
the neurites become more densely packed,
highly interlaced, and their distal ends
terminate as a uniform growth front.
Growth cones are mostly confined to this
leading edge and are larger than those in
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Figure 3. AChE activity correlates with neurite out-
growth. Neurite outgrowth at increasing concentra-
tions of BW284c51 is expressed as percent of control
and graphed together with the amount of AChE activity
measured in those cultures, which is also expressed as
percent of control. Note the correspondence between
these two curves, which indicates the close correlation
between AChE activity in the culture and degree of
neurite outgrowth.
either control group. Substitution of
immunodepleted MAB304 ascites fluid
eliminates both the detachment of neurites
and retarded outgrowth, indicating that
the effects are due to antibody in the
ascites fluid.
Level ofAChEExpression Is
Modulated bythe racellular Matrix
A potential functional interaction between
AChE and components of the extracellular
matrix is suggested by our results, which
show that AChE levels can be altered by
DRG neurons when they encounter an
extracellular environment that varies in its
degree of permissiveness to outgrowth
(21). As shown in Figure 7, DRG neurons
grown on a substratum of type I collagen
exhibit neurites that are more fasciculated
and less extensive than those on the more
permissive Matrigel substratum. Further-
more, the neurons on type I collagen
express approximately twice as much
AChE as cells grown on Matrigel, suggest-
ing that more AChE is required for growth
on a less permissive substratum.
Discussion
Our studies using cultured DRG neurons
show that AChE levels increase in parallel
with neurite outgrowth and that this expres-
sion can be modulated in response to the
type of substratum. Furthermore, certain
AChE inhibitors produce a dose-dependent,
but reversible, reduction in neurite out-
growth (5,15,17), which is accompanied by
Table 1. Comparison of target specificity and effect on neurite outgrowth of cholinesterase inhibitors.
Compound Enzyme target Effect on outgrowth Reference
BW284c51 AChE ++++ Bataille et al., 1998(38)
Bigbee and DeVries, 1987 (17)
Dupree and Bigbee, 1994, 1996 (18,20)
Jones et al., 1995 (29)
Layer et al., 1993 (30)
Small et al., 1995 (28)
Srivatsan and Peretz, 1997 (39)
Physostigmine AChE ++ Dupree and Bigbee, 1996 (20)
Edrophonium AChE + Small et al., 1995(28)
Srivatsan and Peretz, 1997 (39)
Ecothiophate AChE/BChE Jones et al., 1995 (29)
Layer et al., 1993 (30)
DFP AChE/BChE Dupree and Bigbee, 1996 (20)
Jones et al., 1995 (29)
Small et al., 1995 (28)
iso-OMPA BChE Dupree and Bigbee, 1994, 1996 (18,20)
Jones et al., 1995(29)
Layer et al., 1993 (30)
Srivatsan and Peretz, 1997 (39)
Figure 4. AChE inhibitor treatment produces neurofilament accumulations. DRG neurons were grown for 10 days in the presence of BW284c51 at 10-4 M concentration and
examined by immunofluorescence (A) and transmission electron microscopy (B). In A, a monoclonal antibody to the low molecular weight protein subunit of neurofilaments
reveals a large accumulation of immunoreactive material in nearly half of the cell bodies (arrows). Electron microscopy (B) reveals that these masses are composed almost
entirely of neurofilaments with a few trapped organelles (arrows). Bar in A = 50 pm; bar in B= 2.0 pm.
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accumulations ofneurofilaments in the cell
body (15-17). Finally, exposure to an
AChE monoclonal antibody decreases
neurite outgrowth as well as altering the
morphology of that outgrowth (22).
Collectively, these data strongly support a
morphogenic role for AChE in neurite out-
growth. Moreover, our findings that AChE
antibody treatment can also cause rapid
detachment ofneurites from the substratum
(22) furthersuggest thatAChE functions by
an adhesive mechanism. We are currently
attempting to identify the reactive epitope
for MAB304 on the AChE molecule and to
determine the proximity ofthat site to the
opening ofthe active site gorge. In doing so
we may be able to determine ifthe perturba-
tion in neurite outgrowth resulting from
anti-AChE antibody treatment involves a
site related to, or more distant, from the
site(s) occupied by pharmacologic agents,
i.e., BW284c51 orphysostigmine.
The direct involvement ofAChE in
process outgrowth has been demonstrated
'e
* x:
' - #. U
Ae k .1
.c.t
Control MAB304
Figure 5. Short-term, high-dose antibody treatment causes neurite detachment. Ten-day-old cultures were treated for 1-3 hrwith 200pg/mI of MAB304. The darkfield micro-
graph of the untreated culture (left panel) shows the radially oriented pattern of neurite outgrowth with the central plating area beyond the bottom of the field. Within 2 hr of
antibody addition (right panel) the distal neurites had detached and continued to detach centripetallywith time. Removal of the antibody resulted in resumed neurite outgrowth
within 8-12 hr. No complement activitywas detected in the culture medium. Bar= 1 mm in both panels.
]
N
Figure 6. Long-term, low-dose antibody treatment reduces neurite outgrowth. DRG neuron cultures were treated for 6 days with either 20pg/mI MAB304 (A-C) or normal
mouse lgG (D-F). Panels A and Dare low magnification images of an entire culture showing the central plating area containing the DRG neuronal cell bodies and radially ori-
ented neurite outgrowth. The extent ofthe outgrowth is indicated by a computer-generated perimeter thatwas used to calculate the total outgrowth area. Antibody treatment
resulted in a 50% reduction in outgrowth based on measurements from a minimum of 12 cultures obtained from three independent experiments. Panels Band Eare low magni-
fication scanning electron micrographs taken from the outgrowth margins indicated by the boxes in A and D. Note that MAB304 treatment (B) produced a more densely inter-
lacing pattern of outgrowth that terminates at a very uniform leading edge compared with normal lgG control (E). In addition, the growth cones are larger and restricted to the
outgrowth margin in antibody-treated cultures (C). Bar in D=0.5 cm forpanels A and D; bar in E=250 pm for panels Band E; bar in F=25 pm for panels Cand F. Reproduced
from Bigbee and Sharma(46)with permission from Plenum Press.
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Figure 7. Effects of culture substratum on AChE expression. Photomicrographs of DRG grown for 4 days on
collagen type or Matrigel and stained histochemically for AChE activity. These experiments were performed with
nondissociated ganglia to eliminate the large amount of cellular migration that occurs on Matrigel. Note the
intense, dark staining of both the ganglia (g) and neurites (arrows) on the collagen substratum, which contrasts
with the lower activity seen on Matrigel. AChE activity is-barely detectable in the neurites (arrows). Bar =350 ,um
in both panels.
in recent studies in which the expression of
AChE was genetically manipulated.
Overexpression of AChE in cell lines
(33,34), spinal neurons (35), or retinal
cells (36) caused increased outgrowth that
paralleled the level of AChE expression.
Conversely, decreasing the expression of
AChE, using antisense techniques, reduced
outgrowth (34,37).
Other in vitro studies employing a vari-
ety of neuronal cell types have reported
retardation ofneurite outgrowth in response
to AChE inhibitor treatment. These studies
used chick tectal and retinal ganglion neu-
rons (30), rat sympathetic ganglion neurons
(28), dopaminergic midbrain neurons (29),
spinal motor neurons (38), and Aplysia
pedal ganglion neurons (39). These studies
show that the most potent inhibitor ofout-
growth was BW284c5 1, which occupies
both the catalytic and the peripheral anionic
sites ofthe active center gorge ofAChE. On
the basis of the crystallographic data for
AChE complexed with the AChE inhibitor
decamethonium, which is also a linear, bis-
quaternary nitrogen compound (40), it is
likely that the BW284c51 molecule extends
beyond the opening of the gorge. In this
orientation, BW284c51 could interfere
with the proposed secondary growth-related
site (30). Thus, examination of the physic-
ochemical properties ofAChE inhibitors
may provide additional clues about the
location and/or nature ofthis secondary site
on AChE.
Agricultural and household pesticides
that target AChE could interfere with this
noncholinergic role ofAChE if exposure
occurs during critical periods ofnervous sys-
tem development. As indicated earlier, DFP
has no effect on neurite growth; however, a
preliminary report (41) shows that a
different organophosphate compound,
chlorpyrifos (Dursban), decreases neurite
outgrowth in cultured PC-12 cells. In
human and animal studies, prenatal expo-
sure to chlorpyrifos produces cellular and
behavioral neurotoxicity (42-44); in the
human study (44), CNS abnormalities were
consistently noted, including structural
defects in the ventricles and corpus callo-
sum. Interestingly, young animals exhibit an
increased susceptibility to organophospho-
rus insecticides (45), suggesting the neces-
sity of further study to determine if these
agents pose a teratogenic threat during criti-
cal periods ofgestation. Because the devel-
opmental, morphogenic role for AChE in
axonal growth is now well established, cur-
rent research is directed toward understand-
ing the mechanism ofaction and regulation
ofexpression ofthis protein.
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